Health Policy Watch Reporting on Covid-19
- Funded by Wellcome Trust
- Total publications:0 publications
Grant number: 222217/Z/20/Z
Grant search
Key facts
Disease
COVID-19Start & end year
20202021Known Financial Commitments (USD)
$317,378.43Funder
Wellcome TrustPrincipal Investigator
Dr. Carolyn Deere BirkbeckResearch Location
SwitzerlandLead Research Institution
Global Policy ReportingResearch Priority Alignment
N/A
Research Category
Policies for public health, disease control & community resilience
Research Subcategory
Communication
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Reliable, evidence-based media remains a key means of advancing public health literacy and bringing news, views and opinions from diverse regions of the world into the corridors of power. The vision driving Health Policy Watch, launched in 2019 as an open-access, non-profit health news service, is to create a new "network paradigm" that connects the dots between policy trends and realities in the global North and South. We provide coverage across 5 key themes, including: infectious diseases; non-communicable diseases; antimicrobial resistance; climate and environmental health; and health emergencies. The key objective of this proposal is to foster a more balanced- and "solutions"-oriented approach to health policy dialogue around issues and choices that are critical to effective response to the COVID-19 pandemic - and to the broader global health agenda in light of COVID-19 realities. Institutional sustainability is a second key objective. To realize its public service mission, Health Policy Watch is committed to ensuring that all potential readers can access our content free of charge. As we work, with modest resources, to build a diverse array of donors and collaborations to advance that mission, Wellcome Trust support would empower us to develop a more sustainable and robust funding portfolio.